Arkolith/Insider Trading/CGEM/Form 4

Lynx1 Capital Management LP

10% OwnerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Oct 10, 2025
Net Buying
Open-Market Buys
$9.8M
Open-Market Sells
$0
Net Open-Market Flow
$9.8M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 10, 2025Buy(P)277K$7.36$2.0M8.5M
Oct 9, 2025Buy(P)626K$6.70$4.2M8.3M
Oct 8, 2025Buy(P)556K$6.46$3.6M7.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-004379) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML